UK Health Agency Warns Against Unsafe Weight-Loss Products This New Year
Caution Advised for Weight-Loss Medicines
New Delhi, Dec 30: As the New Year approaches, many individuals are inclined to commit to healthier habits and lifestyle changes. However, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning urging consumers to ensure that any weight-loss medications they consider are safe, effective, and legally obtained.
The MHRA cautioned against the significant dangers associated with purchasing weight-loss products from unregulated online platforms or social media channels. These products may be counterfeit, contaminated, improperly dosed, or contain potent ingredients that are not disclosed on their labels, according to a statement released by the agency.
Such products can result in severe health issues, including heart complications, psychological effects, and dangerously low blood sugar levels.
UK's Health Minister Zubir Ahmed, who is also a practicing physician, emphasized that licensed obesity medications can be beneficial for those with a clinical need, but they should only be obtained from registered pharmacies with a valid prescription.
The MHRA strongly advises against purchasing prescription-only medications without a prescription and encourages sourcing medicines from authorized pharmacies or reputable retailers.
Additionally, the agency warns against weight-loss products advertised on social media, particularly those that promise rapid results, miraculous outcomes, or unusually low prices, which are often indicative of illegal sellers.
For anyone considering weight-loss treatments, consulting with a general practitioner, qualified medical doctor, pharmacist, or other healthcare professionals is recommended.
"During this time of year, many seek ways to enhance their health, but acquiring medicines from illegal online vendors poses a genuine risk to your well-being. Always ensure you are using authorized products from legitimate sources and consult a healthcare professional for guidance on safe, evidence-based options," stated Jenn Matthissen from the MHRA's Safety and Surveillance team.
The MHRA, an executive agency under the UK's Department of Health and Social Care, oversees the regulation of all medicines and medical devices in the country, ensuring their efficacy and safety.
Previously, the US Food and Drug Administration (FDA) also issued warnings regarding unapproved weight-loss drugs, labeling them as hazardous for patients since they do not undergo the FDA's rigorous safety, effectiveness, and quality assessments before being marketed.